Throughput Is the Buying Criterion

The buying criterion is throughput: treatments per hour, multiplied by the hours the clinic can schedule, multiplied by what each treatment contributes after consumables. Everything else about the platform is secondary to that calculation.

Two consequences follow. First, the specification question is really a scheduling question: treatment speed, room turnaround, and handpiece handling determine how many sessions fit in a day, and a slower platform with a lower price is more expensive per hour of capacity. Second, consumable cost per treatment has to be modeled at that volume, because high throughput consumes optics faster. Where a clinic cannot state its treatments per hour at realistic utilization, the purchase is being decided on a figure that will not describe the business.

Configuration and Optics Options

Configuration and optics determine both treatment speed and running cost, so they should be selected against the throughput model rather than against a specification sheet.

The practical point about configuration is redundancy. In a high-volume service, a single handpiece failure stops revenue, so a spare is not a luxury but part of the throughput assumption. That spare’s cost belongs in the purchase budget rather than in the first month’s surprise.

Session Volume and Room Scheduling Fit

Session volume is a scheduling constraint before it is a demand constraint, and the two are often confused. A clinic may have demand for the treatment and still be unable to deliver it at the assumed rate.

• Treatments per hour achievable with the platform, under the clinic’s own protocols.
• Room turnaround time, including preparation, consent, and aftercare instructions.
• Practitioner availability, which usually constrains throughput before the machine does.
• Booking patterns, since a service sold in short sessions consumes more slots than the same revenue in longer ones.
• Peak demand periods, and whether the schedule can absorb them without extending opening hours.

One scheduling factor is often overlooked: consent, patch testing, and aftercare instructions consume staff time even when they do not consume room time, and at high volume those minutes accumulate into a staffing requirement rather than a documentation task.

The realistic figure is treatments per week, not treatments per hour in isolation. A platform that delivers fast sessions but requires a long turnaround still constrains daily volume, and a clinic that cannot staff the additional hours has a capacity constraint the equipment cannot solve.

Running Cost: Optics, Consumables, Power

Running cost on a high-volume platform is dominated by delivery components, because the same optics that produce the throughput are consumed in producing it. The figure to model is consumable cost per treatment, not per month.

• Handpiece and optics cost divided by the treatments each supports.
• Components consumed per session, which varies with treatment area and protocol.
• Any coupling or protective consumables used per treatment.
• Power and cooling requirements, which matter more at high duty cycles.
• Stock holding: the inventory of spares needed to protect the schedule.

Because consumable cost scales with volume while the console cost does not, cost per treatment falls as utilization rises. That is the mechanism that makes high-volume platforms economical and low-volume ownership expensive, and it is why the volume assumption in the model deserves more scrutiny than the purchase price.

Verification for a Pre-Owned Unit

Verification follows the sequence used for any pre-owned platform, with extra weight on the delivery components, because those are what the business depends on.

• Serial numbers matching across the console, its documentation, and any service record.
• Ownership evidence, and confirmation that no finance or lease interest remains.
• Handpiece and optics condition, with remaining life stated per component.
• Software release, licensing, and transferability.
• Clearance and labeling position for the intended treatments.
• Service and calibration records, dated and attributed to a named provider.

One question is specific to high-volume purchases: how many handpieces are included, and whether that number supports the throughput assumption. A platform supplied with one handpiece and no spare effectively caps the schedule, because a failure cannot be absorbed. Regulatory references should be checked for the operating market, with the FDA medical device portal as the US starting point and EUR-Lex covering the EU position including MDR 2017/745.

Support, Parts and Calibration

Support terms matter more on a high-volume platform than on most equipment, because downtime is measured in lost appointments rather than in inconvenience. Response commitments should be read as commercial terms rather than service literature.

• Who performs service and calibration, and whether capability exists independently of the original vendor.
• Response commitment for a fault, and the downtime the clinic should plan to absorb.
• Whether the agreement covers handpieces and optics or excludes them as consumables.
• Parts and consumable lead times, and whether supply has more than one channel.
• Whether a loan handpiece is available during repair, which directly protects throughput.

Maintenance expectations should be benchmarked against recognized practice rather than agreed informally, and bodies such as AAMI publish equipment-maintenance guidance that clinical engineering functions use to define intervals and documentation. Electrical safety expectations for medical electrical equipment sit in the IEC 60601 series, so an up-to-date electrical safety test record belongs in the file for any pre-owned powered platform, and independent alert reporting such as that published by ECRI is the customary check on a model’s field-safety history.

Cost Bands Across Routes

The routes price different levels of assurance, and in a high-volume setting the assurance that matters most is the optics and handpiece position rather than cosmesis or hours.

Two further lines belong in the term cost on a high-volume platform: the working capital tied up in spare handpieces and consumables held against a stockout, and the cost of any loan unit arrangement during service. Neither appears on the invoice and both affect the real cost of running the schedule.

As-is suits a buyer with engineering capability and a store of spares. It is a poor fit for a clinic whose schedule depends on the platform running every day, because the risk transferred is precisely the risk that stops the schedule. Claims about treatment outcomes should be assessed against the device’s documented intended use and published literature rather than promotional material, with material from professional societies such as the American College of Radiology as a reasonable reference for how clinical evidence is judged.

Comparison Table: Acquisition Routes

A normalized comparison keeps the decision on capability rather than on price, and it should be completed before any negotiation begins.

Before signing or accepting delivery, verify:

• Configuration and handpiece count, itemized, including any spare.
• Optics and handpiece condition with remaining life per component.
• Consumable cost per treatment, calculated rather than quoted.
• Software release, licensing, and transferability.
• Clearance and labeling position for the intended treatments.
• Service terms including response commitment and any loan-unit provision.
• Parts and consumable lead times, and the number of supply channels.
• Trade-in credit terms where an outgoing unit is involved.

When a Smaller Platform Fits Better

A high-throughput platform is the right purchase only when the clinic can fill it. Where volume is lower, a smaller configuration usually produces a better return, because the fixed cost is spread over fewer treatments.

• Where weekly volume is well below the platform’s practical capacity, the fixed cost per treatment stays high.
• Where the caseload concentrates in a narrow treatment range, a broader platform is unused capability.
• Where room or staffing cannot support the additional sessions, throughput is capped regardless of the equipment.
• Where optics cost per treatment is high relative to the local price band, the margin may not clear.
• Where demand is seasonal, capacity sized for the peak is idle for part of the year.

The honest conclusion in those cases is not that the platform is unsuitable but that the volume does not justify it yet. Building the schedule first and buying second is cheaper than holding capacity that does not fill, and the throughput model gives the clinic a defensible answer either way. Providers working through that assessment can compare platform categories through modality and category selection, review what a verified used unit involves under pre-owned and refurbishment, and submit a configuration through a quotation request.

Questions Buyers Ask